Ir al contenido
Gracias por visitar el sitio Web de First Coast Service Options. Este sitio Web es exclusivamente para que los proveedores de Medicare y profesionales del cuidado de la salud encuentren noticias recientes de Medicare y la información que afecta a la comunidad del proveedor.
Para poder presentarle un contenido personalizado enfocado en su área de interés, por favor seleccione sus preferencias a continuación:
Seleccione lo que mejor lo describe:
Seleccione su localización:
Seleccione su línea de negocio:

Al hacer clic en Continuar a continuación, acepta lo siguiente:

LICENCIA DE USO DE "CURRENT PROCEDURAL TERMINOLOGY DE MÉDICOS" (CPT), CUARTA EDICIÓN
Acuerdo de Usuario Final/Señalar y Hacer Clic: los códigos CPT, las descripciones y otros datos solo están protegidos por los derechos de autor de 2022 de la American Medical Association (AMA). Todos los derechos reservados (y otra fecha de publicación de CPT). CPT es una marca registrada de la AMA.

Usted, sus empleados y agentes están autorizados a utilizar CPT solamente como figura en los siguientes materiales autorizados:

Determinaciones de Cobertura Local (LCDs),

Políticas de Revisión Médica Local (LMRPs),

Boletines/Hojas Informativas,

Memorandos del Programa e Instrucciones de Facturación,

Políticas de Cobertura y Codificación,

Boletines e Información de Integridad del Programa,

Materiales Educacionales/de Capacitación,

Correos especiales,

Tarifas Fijas;

internamente dentro de su organización dentro de los Estados Unidos para su propio uso, el de sus empleados y agentes. El uso está limitado al uso en Medicare, Medicaid u otros programas administrados por los Centros de Servicios de Medicare y Medicaid (CMS), anteriormente conocido como Administración de Financiamiento de Cuidado de la Salud (HCFA, Health Care Financing Administration). Usted acepta tomar todas las medidas necesarias para asegurarse que sus empleados y agentes cumplan con los términos de este acuerdo. Cualquier uso no autorizado en este documento está prohibido, incluyendo a manera de ilustración y no a manera de limitación, haciendo copias de CPT para la reventa y/o licencia, transfiriendo copias de CPT a cualquier parte que no esté atada por este acuerdo, creando cualquier trabajo modificado o derivado de CPT, o hacer cualquier uso comercial de CPT. La licencia para utilizar CPT para cualquier uso no autorizado aquí debe obtenerse a través de la AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Las aplicaciones están disponibles (en inglés) en el sitio web de AMA. Las restricciones aplicables de FARS/DFARS se aplican al uso del gobierno.

Aviso Legal de Garantías y Responsabilidades de la AMA

CPT se proporciona "tal cual" sin garantía de ningún tipo, ya sea expresa o implícita, incluidas, entre otras, las garantías implícitas de comerciabilidad e idoneidad para un fin determinado. No se incluyen tarifas fijas, unidades básicas, valores relativos o listados relacionados en CPT. La AMA no ejerce la medicina de forma directa o indirecta ni administra servicios médicos. La responsabilidad por el contenido de este archivo/producto es con CMS y no está respaldado o implícito por parte de la AMA. La AMA no se hace responsable de las consecuencias o responsabilidades atribuibles o relacionadas con el uso, el no uso o la interpretación de la información contenida o no en este archivo/producto. Este acuerdo se dará por terminado con un aviso si usted viola sus términos. La AMA es una tercera parte beneficiaria de este acuerdo.

Aviso Legal de CMS

El alcance de esta licencia está determinado por la AMA, el titular de los derechos de autor. Cualquier pregunta relacionada con la licencia o el uso de CPT debe dirigirse a la AMA. Los usuarios finales no actúan en nombre o representación de CMS. CMS NIEGA LA RESPONSABILIDAD POR CUALQUIER RESPONSABILIDAD ATRIBUIBLE AL USUARIO FINAL DEL USO DE CPT. CMS NO SERÁ RESPONSABLE POR NINGUNA DEMANDA ATRIBUIBLE A CUALQUIER ERROR, OMISIÓN U OTRAS INEXACTITUDES EN LA INFORMACIÓN O MATERIAL CONTENIDO EN ESTA PÁGINA. En ningún caso, CMS será responsable por daños directos, indirectos, especiales, incidentales o consecuentes que surjan del uso de tal información o material.

AMA – Derechos del Gobierno de los EE.UU.

Este producto incluye CPT, que es información técnica comercial y/o bases de datos informáticas y/o software informático comercial y/o documentación de software comercial, según corresponda, desarrollada exclusivamente a costo privado por la American Medical Association, 515 North State Street, Chicago, Illinois, 60610. Los derechos del gobierno de EE. UU. para utilizar, modificar, reproducir, publicar, presentar, exhibir o divulgar esta información técnica y/o bases de datos informáticas y/o software informático y/o documentación de software informático están sujetos a restricciones de derechos limitadas de DFARS 252.227-7015 (b) (2) (junio de 1995) y/o sujeto a las restricciones de DFARS 227.7202-1 (a) (junio de 1995) y DFARS 227.7202-3 (a) (junio de 1995), según corresponda para las adquisiciones del Departamento de Defensa de EE.UU. y restricciones de derechos limitadas de FAR 52.227-14 (junio de 1987) y/o sujeto a las disposiciones de derechos restringidos de FAR 52.227-14 (junio de 1987) y FAR 52.227-19 (junio de 1987), según corresponda, y cualquier agencia aplicable de suplementos de FAR, para adquisiciones no realizadas por el Departamento Federal.

CURRENT DENTAL TERMINOLOGY, (CDT) de ADA

Acuerdo de Usuario Final/Señalar y Hacer Clic: Estos materiales contienen Current Dental Terminology (CDTTM), Copyright © 2022 American Dental Association (ADA). Todos los derechos reservados. CDT es una marca registrada de ADA.

LA LICENCIA CONCEDIDA EN ESTE ACUERDO ESTÁ EXPRESAMENTE CONDICIONADA AL ACEPTAR TODOS LOS TÉRMINOS Y CONDICIONES CONTENIDOS EN ESTE ACUERDO. AL HACER CLIC EN EL BOTÓN ETIQUETADO "ACEPTAR", USTED RECONOCE QUE HA LEÍDO, COMPRENDIDO Y ACEPTADO TODOS LOS TÉRMINOS Y CONDICIONES ESTABLECIDOS EN ESTE ACUERDO.

SI NO ESTÁ DE ACUERDO CON TODOS LOS TÉRMINOS Y CONDICIONES ESTABLECIDOS AQUÍ, HAGA CLIC EN EL BOTÓN ETIQUETADO "DECLINAR" Y SALGA DE ESTA PANTALLA DEL ORDENADOR.

SI USTED ACTÚA EN NOMBRE DE UNA ORGANIZACIÓN, DECLARA QUE ESTÁ AUTORIZADO PARA ACTUAR EN NOMBRE DE DICHA ORGANIZACIÓN Y QUE SU ACEPTACIÓN DE LOS TÉRMINOS DE ESTE ACUERDO CREA UNA OBLIGACIÓN LEGALMENTE IMPONIBLE DE LA ORGANIZACIÓN. SEGÚN SE UTILIZA AQUÍ, "USTED" Y "SU" SE REFIEREN A USTED Y A CUALQUIER ORGANIZACIÓN EN NOMBRE DE LA QUE ACTúA.

Sujeto a los términos y condiciones contenidos en este Acuerdo, usted, sus empleados y agentes están autorizados a utilizar CDT solamente según se contiene en los siguientes materiales autorizados y expresamente para uso interno por usted mismo, sus empleados y agentes dentro de su organización dentro de los Estados Unidos y sus territorios. El uso de CDT está limitado a uso en programas administrados por los Centros de Servicios de Medicare y Medicaid (CMS). Usted está de acuerdo en tomar todos los pasos necesarios para asegurar que sus empleados o agentes se atengan a los términos de este acuerdo. Usted reconoce que la ADA tiene todos los derechos de autor, marcas y otros derechos en CDT. Usted no eliminará, alterará, u ocultará ninguna notificación de derechos de autor de ADA u otras notificaciones de derechos de propiedad incluidas en los materiales.

Cualquier uso no autorizado en este documento está prohibido, incluyendo a manera de ilustración y no a manera de limitación, haciendo copias de CDT para la reventa y/o licencia, transfiriendo copias de CDT a cualquier parte que no esté atada por este acuerdo, creando algún trabajo modificado o derivado de CDT, o haciendo uso comercial de CDT. La licencia para utilizar CDT para cualquier uso no autorizado aquí debe ser obtenido a través del American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Las aplicaciones están disponibles (en inglés) en el sitio web de ADA

Cláusulas Aplicables de Regulación de Adquisición Federal (FARS)\Departamento de restricciones aplica a uso Gubernamental.

AVISO LEGAL DE GARANTÍAS Y RESPONSABILIDADES DE LA ADA: CPT se proporciona "tal cual" sin garantía de ningún tipo, ya sea expresa o implícita, incluidas, entre otras, las garantías implícitas de comerciabilidad e idoneidad para un fin determinado. No se incluyen tarifas fijas, unidades básicas, valores relativos o listados relacionados en CDT. La ADA no ejerce la medicina de forma directa o indirecta ni administra servicios dentales. La total responsabilidad del software, incluyendo cualquier CDT y otro contenido incluido en el mismo, es con (incluya el nombre de la entidad aplicable) o con CMS; y ningún endorso por la ADA es intencionado o implicado. La ADA no se hace responsable de las consecuencias o responsabilidades atribuibles o relacionadas con el uso, el no uso o la interpretación de la información contenida o no en este archivo/producto. Este acuerdo se dará por terminado con un aviso si usted viola sus términos. La ADA es una tercera parte beneficiaria de este acuerdo.

AVISO LEGAL DE CMS: El alcance de esta licencia está determinado por la ADA, el propietario de los derechos de autor. Cualquier pregunta relacionada a la licencia de uso del CDT debe ser presentada a la ADA. Los usuarios finales no actúan para o en representación de CMS. CMS NIEGA RESPONSABILIDAD POR CUALQUIER OBLIGACIÓN ATRIBUIBLE AL USO DEL CDT POR EL USUARIO FINAL. CMS NO SERÁ RESPONSABLE POR CUALQUIER RECLAMACIÓN ATRIBUIBLE A CUALQUIER ERROR, OMISIÓN,O CUALQUIER OTRA INEXACTITUD EN LA INFORMACIÓN O MATERIAL CUBIERTO POR ESTA LICENCIA. En ningún evento será CMS responsable por daños directos, indirectos, especiales, incidentales, o consecuentes que surjan fuera del uso de tal información o material.

El propósito de este sitio Web es proporcionar información y noticias sobre el programa de Medicare solamente para los profesionales de la salud. Todas las comunicaciones y los temas relacionados con sus beneficios de Medicare son manejados directamente por Medicare y no a través de este sitio Web. Para una experiencia más completa, le recomendamos que visite Medicare.gov o llame al 1-800-MEDICARE. En caso que su proveedor no presente su reclamación de Medicare consulte estos recursos para recibir asistencia con la misma.
Únase eNews       In English
Tamaño de texto:
YouTube LinkedIn Email Imprima
Enviar un enlace a esta página
[Múltiples direcciones de email deben estar separadas por punto y coma.]
Last Modified: 12/20/2024 Location: FL, PR, USVI Business: Part A, Part B

Códigos T de Categoría III de CPT que requieren documentación

Evite impactos negativos en sus reclamaciones proporcionando registros médicos con su Presentación de reclamación inicial para los códigos T que se enumera a continuación (en inglés). Para obtener detalles, vea nuestro artículo sobre el Nuevo proceso para los códigos T de Categoría III de CPT.

Código
Descripción
Vigente “desde” fecha de servicio
Vigente “hasta” fecha de servicio
0174T
Computer algorithm analysis of digital image data
2/26/2024
Presente
0175T
Remote computer algorithm analysis of digital image data
2/26/2024
Presente
0253T
Insertion of anterior segment aqueous drainage device, without extraocular reservoir, internal approach, into the suprachoroidal space
2/26/2024
Presente
0263T
Intramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; complete procedure
2/26/2024
Presente
0264T
Intramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; complete procedure excluding bone marrow harvest
2/26/2024
Presente
0265T
Intramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; unilateral or bilateral bone marrow harvest only for intramuscular autologous bone marrow cell therapy
2/26/2024
Presente
0333T
Visual evoked potential, screening of visual acuity, automated, with report
2/26/2024
Presente
0335T
Insertion of sinus tarsi implant
2/26/2024
Presente
0338T
Destruction of nerves of arteries of both kidneys accessed through the skin with fluoroscopy and radiological supervision and interpretation
2/26/2024
Presente
0339T
Destruction of nerves of arteries of one kidney accessed through the skin with fluoroscopy and radiological supervision and interpretation
2/26/2024
Presente
0342T
Therapeutic apheresis with selective hdl delipidation and plasma reinfusion
2/26/2024
Presente
0345T
Transcatheter mitral valve repair percutaneous approach via the coronary sinus
2/26/2024
Presente
0373T
Adaptive behavior treatment with protocol modification, each 15 minutes of technicians' time face-to-face with a patient, requiring the following components: administration by the physician or other qualified health care professional who is on site; with the assistance of two or more technicians; for a patient who exhibits destructive behavior; completion in an environment that is customized to the patient's behavior.
2/26/2024
Presente
0379T
Visual field assessment, with concurrent real time data analysis and accessible data storage with patient-initiated data transmitted to a remote surveillance center for up to 30 days; technical support and patient instructions, surveillance, analysis, and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional
2/26/2024
Presente
0402T
Collagen cross-linking of cornea, including removal of the corneal epithelium, when performed, and intraoperative pachymetry, when performed
2/26/2024
Presente
0403T
Preventive behavior change, intensive program of prevention of diabetes using a standardized diabetes prevention program curriculum, provided to individuals in a group setting, minimum 60 minutes, per day
2/26/2024
Presente
0422T
Tactile breast imaging by computer-aided tactile sensors, unilateral or bilateral
2/26/2024
Presente
0443T
Real-time spectral analysis of prostate tissue by fluorescence spectroscopy, including imaging guidance (List separately in addition to code for primary procedure)
2/26/2024
Presente
0444T
Initial placement of a drug-eluting ocular insert under one or more eyelids, including fitting, training, and insertion, unilateral or bilateral
2/26/2024
Presente
0445T
Subsequent placement of a drug-eluting ocular insert under one or more eyelids, including re-training, and removal of existing insert, unilateral or bilateral
2/26/2024
Presente
0450T
Insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; each additional device (List separately in addition to code for primary procedure)
2/26/2024
Presente
0469T
Retinal polarization scan, ocular screening with on-site automated results, bilateral
2/26/2024
Presente
0474T
Insertion of anterior segment aqueous drainage device, with creation of intraocular reservoir, internal approach, into the supraciliary space
2/26/2024
Presente
0481T
Injection(s), autologous white blood cell concentrate (autologous protein solution), any site, including image guidance, harvesting and preparation, when performed
2/26/2024
Presente
0489T
Autologous adipose-derived regenerative cell therapy for scleroderma in the hands; adipose tissue harvesting, isolation and preparation of harvested cells including incubation with cell dissociation enzymes, removal of non-viable cells and debris, determination of concentration and dilution of regenerative cells
2/26/2024
Presente
0490T
Autologous adipose-derived regenerative cell therapy for scleroderma in the hands; multiple injections in one or both hands
2/26/2024
Presente
0494T
Surgical preparation and cannulation of marginal (extended) cadaver donor lung(s) to ex vivo organ perfusion system, including decannulation, separation from the perfusion system, and cold preservation of the allograft prior to implantation, when performed
2/26/2024
Presente
0495T
Initiation and monitoring marginal (extended) cadaver donor lung(s) organ perfusion system by physician or qualified health care professional, including physiological and laboratory assessment (e.g., pulmonary artery flow, pulmonary artery pressure, left atrial pressure, pulmonary vascular resistance, mean/peak and plateau airway pressure, dynamic compliance and perfusate gas analysis), including bronchoscopy and X ray when performed; first two hours in sterile field
2/26/2024
Presente
0496T
Initiation and monitoring marginal (extended) cadaver donor lung(s) organ perfusion system by physician or qualified health care professional, including physiological and laboratory assessment (e.g., pulmonary artery flow, pulmonary artery pressure, left atrial pressure, pulmonary vascular resistance, mean/peak and plateau airway pressure, dynamic compliance and perfusate gas analysis), including bronchoscopy and X ray when performed; each additional hour (List separately in addition to code for primary procedure)
2/26/2024
Presente
0506T
Macular pigment optical density measurement by heterochromatic flicker photometry, unilateral or bilateral, with interpretation and report
2/26/2024
Presente
0511T
Removal and reinsertion of sinus tarsi implant
2/26/2024
Presente
0541T
Imaging of heart muscle using magnetocardiography to detect deficient blood flow, single study
2/26/2024
Presente
0542T
Interpretation and report of imaging of heart muscle using magnetocardiography to detect deficient blood flow
2/26/2024
Presente
0547T
Bone material quality testing by microindentations of shin bone
2/26/2024
Presente
0554T
Bone strength and fracture risk assessment: retrieval and transmission of CT scan data, assessment of bone strength and fracture risk and bone mineral density, interpretation and report
2/26/2024
Presente
0555T
Bone strength and fracture risk assessment: retrieval and transmission of CT scan data only
2/26/2024
Presente
0556T
Bone strength and fracture risk assessment: assessment of bone strength and fracture risk and bone mineral density
2/26/2024
Presente
0557T
Bone strength and fracture risk assessment: interpretation and report
2/26/2024
Presente
0558T
CT scan for biomechanical computed tomography analysis
2/26/2024
Presente
0559T
Anatomic model 3D-printed from image data set(s); first individually prepared and processed component of an anatomic structure
2/26/2024
Presente
0560T
Anatomic model 3D-printed from image data set(s); each additional individually prepared and processed component of an anatomic structure (List separately in addition to code for primary procedure)
2/26/2024
Presente
0561T
Anatomic guide 3D-printed and designed from image data set(s); first anatomic guide
2/26/2024
Presente
0562T
Anatomic guide 3D-printed and designed from image data set(s); each additional anatomic guide (List separately in addition to code for primary procedure)
2/26/2024
Presente
0564T
Evaluation of toxicity of chemotherapy drugs on cancer stem cells
2/26/2024
12/31/2024
0567T
Blockage of fallopian tubes with implants inserted through cervix
2/26/2024
12/31/2024
0568T
Introduction of saline and air into fallopian tubes to test for blockage
2/26/2024
12/31/2024
0584T
Transplantation of insulin-producing cells, via catheter accessed through skin using imaging guidance
2/26/2024
Presente
0585T
Transplantation of insulin-producing cells using endoscope inserted through wall of abdomen
2/26/2024
Presente
0586T
Transplantation of insulin-producing cells, open procedure
2/26/2024
Presente
0591T
Face-to-face health and well-being coaching of individual, initial assessment
2/26/2024
Presente
0592T
Face-to-face health and well-being coaching of individual, follow-up session, at least 30 minutes
2/26/2024
Presente
0593T
Face-to-face health and well-being coaching of group, at least 30 minutes
2/26/2024
Presente
0594T
Incision of upper arm bone and insertion of bone-lengthening device in marrow cavity
2/26/2024
Presente
0602T
Measurement of kidney filtration rate using skin sensor and single dose of fluorescent agent
2/26/2024
Presente
0603T
Monitoring of kidney filtration rate using skin sensor and multiple doses of fluorescent agent
2/26/2024
Presente
0604T
Optical coherence tomography (OCT) of retina, remote, patient-initiated image capture and transmission to a remote surveillance center unilateral or bilateral; initial device provision, set-up and patient education on use of equipment
10/1/2024
Presente
0605T
Optical coherence tomography (OCT) of retina, remote, patient-initiated image capture and transmission to a remote surveillance center unilateral or bilateral; remote surveillance center technical support, data analyses and reports, with a minimum of 8 daily recordings, each 30 days
10/1/2024
Presente
0606T
Optical coherence tomography (OCT) of retina, remote, patient-initiated image capture and transmission to a remote surveillance center unilateral or bilateral; review, interpretation and report by the prescribing physician or other qualified health care professional of remote surveillance center data analyses, each 30 days
10/1/2024
Presente
0610T
Transmission of MR spectroscopy data on biomarkers for spinal disc pain
2/26/2024
Presente
0613T
Implantation of shunt in partition between upper heart chambers via catheter, accessed through skin
2/26/2024
Presente
0621T
Laser incision of drainage tissue within eye (trabecular meshwork)
2/26/2024
6/30/2024
0622T
Laser incision of drainage tissue within eye (trabecular meshwork) using ocular endoscope
2/26/2024
Presente
0643T
Implantation of restoration device into left lower chamber of heart through catheter
2/26/2024
Presente
0645T
Implantation of coronary sinus reduction device in heart through catheter
2/26/2024
Presente
0647T
Insertion of gastrostomy tube, percutaneous, with magnetic gastropexy, under ultrasound guidance, image documentation and report
2/26/2024
Presente
0651T
Examination of esophagus and stomach using a magnetically controlled capsule endoscope
2/26/2024
Presente
0656T
Tethering of 7 or fewer lower spine bones
2/26/2024
Presente
0657T
Tethering of 8 or more lower spine bones
2/26/2024
Presente
0660T
Implantation of drug-releasing device in front chamber of eye
2/26/2024
12/31/2024
0661T
Removal and reimplantation of drug-releasing device in front chamber of eye
2/26/2024
Presente
0662T
Scalp cooling, mechanical; initial measurement and calibration of cap
2/26/2024
Presente
0663T
Scalp cooling, mechanical; placement of device, monitoring, and removal of device (List separately in addition to code for primary procedure)
2/26/2024
Presente
0664T
Removal of uterus from cadaver donor
2/26/2024
Presente
0665T
Removal of uterus from living donor
2/26/2024
Presente
0666T
Removal of uterus from living donor using a laparoscope
2/26/2024
Presente
0667T
Transplantation of uterus from donor
2/26/2024
Presente
0668T
Preparation of donor uterus for transplantation
2/26/2024
Presente
0669T
Reconstruction of donor uterus, each vein-to-vein connection
2/26/2024
Presente
0670T
Reconstruction of donor uterus, each artery-to-artery connection
2/26/2024
Presente
0672T
Radiofrequency remodeling of tissues surrounding female bladder neck and proximal urethra for urinary incontinence
2/26/2024
Presente
0674T
Insertion of permanent implantable synchronized diaphragmatic stimulation system for augmentation of heart function, including an implantable pulse generator and diaphragmatic leads, using a laparoscope
2/26/2024
Presente
0675T
Insertion of first lead of permanent implantable synchronized diaphragmatic stimulation system for augmentation of heart function, with connection to existing pulse generator, using a laparoscope
2/26/2024
Presente
0676T
Insertion of additional lead of permanent implantable synchronized diaphragmatic stimulation system for augmentation of heart function, with connection to existing pulse generator, using a laparoscope
2/26/2024
Presente
0677T
Repositioning of first lead of permanent implantable synchronized diaphragmatic stimulation system for augmentation of heart function, with connection to existing pulse generator, using a laparoscope
2/26/2024
Presente
0678T
Repositioning of additional lead of permanent implantable synchronized diaphragmatic stimulation system for augmentation of heart function, with connection to existing pulse generator, using a laparoscope
2/26/2024
Presente
0679T
Removal of permanent implantable synchronized diaphragmatic stimulation system for augmentation of heart function using a laparoscope
2/26/2024
Presente
0680T
Insertion or replacement of pulse generator only of permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, with connection to existing lead
2/26/2024
Presente
0681T
Relocation of pulse generator only of permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, with connection to existing dual leads
2/26/2024
Presente
0682T
Removal of pulse generator only of permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function
2/26/2024
Presente
0683T
In-person programming device evaluation of permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function with analysis, review and report by qualified health care professional
2/26/2024
Presente
0684T
In-person programming device evaluation and programming of permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function before procedure
2/26/2024
Presente
0685T
In-person interrogation device evaluation of permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function with analysis, review and report by qualified health care professional
2/26/2024
Presente
0686T
Acoustic energy destruction of malignant liver tissue using imaging guidance
2/26/2024
Presente
0687T
Device supply, educational set-up, and initial session for online digital treatment of amblyopia
2/26/2024
Presente
0688T
Assessment of patient performance and program data for online digital treatment of amblyopia by healthcare professional with report, per calendar month
2/26/2024
Presente
0689T
Quantitative ultrasound tissue characterization (non-elastographic), including interpretation and report, obtained without diagnostic ultrasound examination of the same anatomy (e.g., organ, gland, tissue, target structure)
2/26/2024
Presente
0691T
Automated analysis of existing CT study for fracture of spine, with data preparation, interpretation, and report
2/26/2024
Presente
0692T
Therapeutic ultrafiltration
2/26/2024
Presente
0693T
Comprehensive full body computer-based markerless 3D motion analysis and report
2/26/2024
Presente
0694T
Real-time 3-dimensional volumetric imaging and reconstruction of breast or axillary lymph node tissue in surgical specimen, with interpretation and report
2/26/2024
Presente
0695T
Body surface-activation mapping of cardiac resynchronization therapy device, with review, and report, at time of implant or replacement
2/26/2024
Presente
0696T
Body surface-activation mapping of cardiac resynchronization therapy device, with review, and report, at time of follow-up device evaluation
2/26/2024
Presente
0700T
Molecular fluorescent imaging of first suspicious mole
2/26/2024
Presente
0701T
Molecular fluorescent imaging of additional suspicious mole
2/26/2024
Presente
0704T
Device supply, initial set-up, and patient education for remote treatment of amblyopia using eye tracking device
2/26/2024
Presente
0705T
Surveillance center technical support for remote treatment of amblyopia using eye tracking device, at least 18 training hours, each 30 days
2/26/2024
Presente
0706T
Health care professional interpretation and report of remote treatment of amblyopia using eye tracking device, per 30 days
2/26/2024
Presente
0708T
Injection of bone-substitute material into defect of bone using imaging guidance and endoscope
2/26/2024
Presente
0709T
Preparation and initial injection of cancer immunotherapy into skin
2/26/2024
Presente
0710T
Additional injection of cancer immunotherapy into skin
2/26/2024
Presente
0711T
Noninvasive analysis of plaque in artery using software processing of CT data, with data preparation and transmission, interpretation and report
2/26/2024
Presente
0712T
Preparation and transmission of data for noninvasive analysis of plaque in artery using software processing of CT data
2/26/2024
Presente
0713T
Evaluation of artery wall and plaque to assess stability of plaque noninvasive analysis of plaque in artery using software processing of CT data
2/26/2024
Presente
0716T
Cardiac acoustic waveform recording with automated analysis and generation of coronary artery disease risk score
2/26/2024
Presente
0717T
Harvesting of patient's own fatty tissue and preparation of cells for autologous adipose-derived regenerative cell (ADRC) therapy for partial thickness rotator cuff tear
2/26/2024
Presente
0718T
Injection of autologous adipose-derived regenerative cell (ADRC) therapy into supraspinatus tendon of one shoulder using ultrasound guidance, for partial thickness rotator cuff tear
2/26/2024
Presente
0719T
Replacement of posterior joint in single segment of spine in lower back (lumbar) using imaging guidance
2/26/2024
Presente
0720T
Electrical nerve field stimulation of cranial nerves through skin
2/26/2024
Presente
0721T
Quantitative computed tomography (CT scan) tissue characterization with interpretation and report
2/26/2024
Presente
0723T
Quantitative magnetic resonance (MR scan) imaging of gallbladder, bile ducts, pancreas and pancreatic duct cholangiopancreatography (QMRCP), with data preparation and transmission, interpretation and report
2/26/2024
Presente
0725T
Implantation of vestibular nerve stimulation device in one ear
2/26/2024
Presente
0726T
Removal of vestibular nerve stimulation device from one ear
2/26/2024
Presente
0727T
Removal and replacement of vestibular nerve stimulation device from one ear
2/26/2024
Presente
0728T
Diagnostic analysis and initial programming of vestibular nerve stimulation device in one ear
2/26/2024
Presente
0729T
Diagnostic analysis and subsequent programming of vestibular nerve stimulation device in one ear
2/26/2024
Presente
0731T
Augmentative artificial intelligence-based analysis of facial features (facial phenotype) for possible genetic syndromes with report
2/26/2024
Presente
0732T
Administration of immunotherapy into muscle using electric pulse (electroporation)
2/26/2024
Presente
0733T
Device supply and technical support for remote real-time, motion capture-based neurorehabilitative therapy, per 30 days
2/26/2024
Presente
0734T
Treatment management service for remote real-time, motion capture-based neurorehabilitative therapy, per calendar month
2/26/2024
Presente
0735T
Preparation of tumor cavity and placement of radiation therapy applicator for intraoperative radiation therapy (IORT) at time of primary incision of skull
2/26/2024
Presente
0736T
Insertion of rectal catheter and flushing of colon with gravity-fed 35 or more liters of water
2/26/2024
Presente
0737T
Implantation of nonhuman tissue graft into surface of joint
2/26/2024
Presente
0750T
Bone strength and fracture-risk assessment using digital X-ray radiogrammetry bone mineral density (DXR-BMD) analysis of bone mineral density (BMD) utilizing data from a digital X ray, retrieval and transmission of digital X ray data, assessment of bone strength and fracture-risk and BMD, interpretation and report; with single-view digital X-ray examination of the hand taken for the purpose of DXR-BMD
2/26/2024
Presente
0766T
Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, initial treatment, with identification and marking of the treatment location, including noninvasive electroneurographic localization (nerve conduction localization), when performed; first nerve
2/26/2024
Presente
0767T
Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, initial treatment, with identification and marking of the treatment location, including noninvasive electroneurographic localization (nerve conduction localization), when performed; each additional nerve (List separately in addition to code for primary procedure)
2/26/2024
Presente
0768T
Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, subsequent treatment, including noninvasive electroneurographic localization (nerve conduction localization), when performed; first nerve
2/26/2024
Presente
0769T
Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, subsequent treatment, including noninvasive electroneurographic localization (nerve conduction localization), when performed; each additional nerve (List separately in addition to code for primary procedure)
2/26/2024
Presente
0770T
Virtual reality technology to assist therapy (List separately in addition to code for primary procedure)
2/26/2024
Presente
0776T
Therapeutic induction of intra-brain hypothermia, including placement of a mechanical temperature-controlled cooling device to the neck over carotids and head, including monitoring (e.g., vital signs and sport concussion assessment tool 5 [SCAT5]), 30 minutes of treatment
2/26/2024
Presente
0778T
Surface mechanomyography (sMMG) with concurrent application of inertial measurement unit (IMU) sensors for measurement of multi-joint range of motion, posture, gait, and muscle function
2/26/2024
Presente
0781T
Bronchoscopy, rigid or flexible, with insertion of esophageal protection device and circumferential radiofrequency destruction of the pulmonary nerves, including fluoroscopic guidance when performed; bilateral mainstem bronchi
2/26/2024
Presente
0782T
Bronchoscopy, rigid or flexible, with insertion of esophageal protection device and circumferential radiofrequency destruction of the pulmonary nerves, including fluoroscopic guidance when performed; unilateral mainstem bronchus
2/26/2024
Presente
0815T
Ultrasound-based radiofrequency echographic multi-spectrometry (REMS), bone-density study and fracture-risk assessment, 1 or more sites, hips, pelvis, or spine
2/26/2024
Presente
0816T
Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (e.g., array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve; subcutaneous
2/26/2024
Presente
0817T
Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (e.g., array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve; subfascial
2/26/2024
Presente
0819T
Revision or removal of integrated neurostimulation system for bladder dysfunction, including analysis, programming, and imaging, when performed, posterior tibial nerve; subfascial
2/26/2024
Presente
0857T
Opto-acoustic imaging, breast, unilateral, including axilla when performed, real-time with image documentation, augmentative analysis and report (List separately in addition to code for primary procedure)
10/1/2024
Presente
0860T
Noncontact near-infrared spectroscopy with provocative maneuvers, image acquisition, interpretation and report for screening for peripheral arterial disease
2/26/2024
Presente
0861T
Removal of pulse generator for wireless cardiac stimulator for left ventricular pacing; both components (battery and transmitter)
2/26/2024
Presente
0862T
Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; battery component only
2/26/2024
Presente
0863T
Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; transmitter component only
2/26/2024
Presente
0865T
Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion identification, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the brain during the same session
2/26/2024
Presente
0877T
Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; obtained without concurrent CT examination of any structure contained in previously acquired diagnostic imaging
7/1/2024
Presente
0878T
Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; obtained with concurrent CT examination of the same structure
7/1/2024
Presente
0879T
Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; radiological data preparation and transmission
7/1/2024
Presente
0880T
Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; physician or other qualified health care professional interpretation and report
7/1/2024
Presente
0881T
Cryotherapy of the oral cavity using temperature regulated fluid cooling system, including placement of an oral device, monitoring of patient tolerance to treatment, and removal of the oral device
2/26/2024
Presente
0882T
Intraoperative therapeutic electrical stimulation of peripheral nerve to promote nerve regeneration, including lead placement and removal, upper extremity, minimum of 10 minutes; initial nerve (List separately in addition to code for primary procedure)
2/26/2024
Presente
0883T
Intraoperative therapeutic electrical stimulation of peripheral nerve to promote nerve regeneration, including lead placement and removal, upper extremity, minimum of 10 minutes; each additional nerve (List separately in addition to code for primary procedure)
2/26/2024
Presente
0887T
End-tidal control of inhaled anesthetic agents and oxygen to assist anesthesia care delivery (List separately in addition to code for primary procedure)
2/26/2024
Presente
0888T
Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including imaging guidance
2/26/2024
Presente
0889T
Personalized target development for accelerated, repetitive high-dose functional connectivity MRI–guided theta-burst stimulation derived from a structural and resting-state functional MRI, including data preparation and transmission, generation of the target, motor threshold–starting location, neuronavigation files and target report, review and interpretation
2/26/2024
Presente
0890T
Accelerated, repetitive high-dose functional connectivity MRI–guided theta-burst stimulation, including target assessment, initial motor threshold determination, neuronavigation, delivery and management, initial treatment day
2/26/2024
Presente
0891T
Accelerated, repetitive high-dose functional connectivity MRI–guided theta-burst stimulation, including neuronavigation, delivery and management, subsequent treatment day
2/26/2024
Presente
0892T
Accelerated, repetitive high-dose functional connectivity MRI–guided theta-burst stimulation, including neuronavigation, delivery and management, subsequent motor threshold redetermination with delivery and management, per treatment day
2/26/2024
Presente
0893T
Noninvasive assessment of blood oxygenation, gas exchange efficiency, and cardiorespiratory status, with physician or other qualified health care professional interpretation and report
2/26/2024
Presente
0894T
Cannulation of the liver allograft in preparation for connection to the normothermic perfusion device and decannulation of the liver allograft following normothermic perfusion
2/26/2024
Presente
0895T
Connection of liver allograft to normothermic machine perfusion device, hemostasis control; initial 4 hours of monitoring time, including hourly physiological and laboratory assessments (e.g., perfusate temperature, perfusate pH, hemodynamic parameters, bile production, bile pH, bile glucose, biliary bicarbonate, lactate levels, macroscopic assessment)
2/26/2024
Presente
0896T
Connection of liver allograft to normothermic machine perfusion device, hemostasis control; each additional hour, including physiological and laboratory assessments (e.g., perfusate temperature, perfusate pH, hemodynamic parameters, bile production, bile pH, bile glucose, biliary bicarbonate, lactate levels, macroscopic assessment) (List separately in addition to code for primary procedure)
2/26/2024
Presente
0901T
Placement of bone marrow sampling port
1/1/2025
Presente
0902T
Augmentative algorithmic analysis of input from an external, patient-activated mobile ECG device to derive QTc interval
1/1/2025
Presente
0903T
Algorithmically generated 12-lead ECG from a reduced-lead ECG
1/1/2025
Presente
0904T
Algorithmically generated 12-lead ECG from a reduced-lead ECG, tracing only
1/1/2025
Presente
0905T
Algorithmically generated 12-lead ECG from a reduced-lead ECG, interpretation and report only
1/1/2025
Presente
0906T
Wound assessment and dressing care using concurrent optical and magnetic stimulation therapy, first application, total wound(s) surface area less than or equal to 50 sq cm
1/1/2025
Presente
0907T
Wound assessment and dressing care using concurrent optical and magnetic stimulation therapy, each additional application, total wound(s) surface area less than or equal to 50 sq cm
1/1/2025
Presente
0908T
Implantation of integrated vagus nerve neurostimulator
1/1/2025
Presente
0909T
Replacement of integrated vagus nerve neurostimulator
1/1/2025
Presente
0910T
Removal of integrated vagus nerve neurostimulator
1/1/2025
Presente
0911T
Electronic analysis of implanted integrated vagus nerve neurostimulator without programming
1/1/2025
Presente
0912T
Electronic analysis of implanted integrated vagus nerve neurostimulator with simple programming
1/1/2025
Presente
0913T
Transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon, with imaging supervision, interpretation, and report, performed on a single major coronary artery or branch
1/1/2025
Presente
0914T
Transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon, performed on a separate target lesion from the target lesion treated with balloon angioplasty, coronary stent placement or coronary atherectomy
1/1/2025
Presente
0915T
Insertion of permanent cardiac contractility modulation-defibrillation system component(s), pulse generator and dual transvenous electrodes/leads
1/1/2025
Presente
0916T
Insertion of permanent cardiac contractility modulation-defibrillation system component(s), pulse generator only
1/1/2025
Presente
0917T
Insertion of permanent cardiac contractility modulation-defibrillation system component(s), single transvenous lead only
1/1/2025
Presente
0918T
Insertion of permanent cardiac contractility modulation-defibrillation system component(s), dual transvenous leads only
1/1/2025
Presente
0919T
Removal of a permanent cardiac contractility modulation-defibrillation system component(s), pulse generator only
1/1/2025
Presente
0920T
Removal of a permanent cardiac contractility modulation-defibrillation system component(s), single transvenous pacing lead only
1/1/2025
Presente
0921T
Removal of a permanent cardiac contractility modulation-defibrillation system component(s), single transvenous defibrillation lead only
1/1/2025
Presente
0922T
Removal of a permanent cardiac contractility modulation-defibrillation system component(s), dual transvenous leads only
1/1/2025
Presente
0923T
Removal and replacement of permanent cardiac contractility modulation-defibrillation pulse generator only
1/1/2025
Presente
0924T
Repositioning of previously implanted cardiac contractility modulation-defibrillation transvenous electrode(s)/lead(s)
1/1/2025
Presente
0925T
Relocation of skin pocket for implanted cardiac contractility modulation-defibrillation pulse generator
1/1/2025
Presente
0926T
In person programming device evaluation with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis
1/1/2025
Presente
0927T
In person interrogation device evaluation of implantable cardiac contractility modulation-defibrillation system with analysis, review, and report, per patient encounter
1/1/2025
Presente
0928T
Remote interrogation device evaluation, up to 90 days, cardiac contractility modulation-defibrillation system with interim analysis and report(s)
1/1/2025
Presente
0929T
Remote interrogation device evaluation, up to 90 days, cardiac contractility modulation-defibrillation system, remote data acquisition(s), receipt of transmissions, technician review, technical support, and distribution of results
1/1/2025
Presente
0930T
Electrophysiologic evaluation of cardiac contractility modulation-defibrillator leads, at time of initial implantation or replacement with testing of cardiac contractility modulation-defibrillator pulse generator
1/1/2025
Presente
0931T
Electrophysiologic evaluation of cardiac contractility modulation-defibrillator leads, separate from initial implantation or replacement with testing of cardiac contractility modulation-defibrillator pulse generator
1/1/2025
Presente
0932T
Detection of heart failure derived from augmentative analysis of an echocardiogram that demonstrated preserved ejection fraction
1/1/2025
Presente
0933T
Transcatheter implantation of wireless left atrial pressure sensor for long-term left atrial pressure monitoring
1/1/2025
Presente
0934T
Remote monitoring of a wireless left atrial pressure sensor for up to 30 days
1/1/2025
Presente
0935T
Bladder exam using a flexible scope with renal pelvic sympathetic denervation using heat
1/1/2025
Presente
0936T
Light therapy of retina, single session
1/1/2025
Presente
0937T
External electrocardiographic recording for more than 15 days up to 30 days by continuous rhythm recording and storage
1/1/2025
Presente
0938T
External electrocardiographic recording for more than 15 days up to 30 days by continuous rhythm recording and storage; recording
1/1/2025
Presente
0939T
External electrocardiographic recording for more than 15 days up to 30 days by continuous rhythm recording and storage; scanning analysis with report
1/1/2025
Presente
0940T
External electrocardiographic recording for more than 15 days up to 30 days by continuous rhythm recording and storage; review and interpretation by a physician or other qualified health care professional
1/1/2025
Presente
0941T
Bladder exam using a flexible scope with insertion and expansion of prostatic urethral scaffold using integrated cystoscopic visualization
1/1/2025
Presente
0942T
Bladder exam of a flexible scope with insertion and expansion of prostatic urethral scaffold using integrated cystoscopic visualization
1/1/2025
Presente
0943T
Bladder exam using a flexible scope with removal of prostatic urethral scaffold
1/1/2025
Presente
0944T
3D contour simulation of target liver lesion(s) and margin(s) for image-guided microwave destruction though skin
1/1/2025
Presente
0945T
Assessment for abnormal tissue, during surgery following partial mastectomy using computer-aided fluorescence imaging
1/1/2025
Presente
0946T
Orthopedic implant movement analysis using paired CT examination of the target structure
1/1/2025
Presente
0947T
Intracranial magnetic resonance image guided low intensity focused ultrasound, stereotactic blood-brain barrier disruption using microbubble resonators to increase the concentration of blood-based biomarkers of target
1/1/2025
Presente
First Coast Service Options (First Coast) se esfuerza por garantizar que la información disponible en nuestro sitio Web del proveedor sea precisa, detallada y actualizada. Sin embargo, este sitio es dinámico y su contenido cambia diariamente. Lo mejor es acceder al sitio Web para asegurarse de contar con la información más actualizada, en lugar de imprimir artículos o formularios que pueden quedar obsoletos sin previo aviso.